Equity Interest. As further consideration, ***** will grant to Stanford shares of (common or preferred) stock in *****. When issued, those shares will represent % of the (common or preferred) stock in ***** on a Fully Diluted Basis. ***** agrees the shares are valued at (ALTERNATIVE: ask company to provide letter stating value of shares as of the Effective Date, and include letter as Appendix D) and to provide Stanford with the capitalization table upon which the above calculation is made. ***** will issue 28.34% of all shares granted to Stanford pursuant to this Section 7.2 and Section
Appears in 5 contracts
Samples: Sample Agreement, Exclusive License Agreement With Equity, Exclusive License Agreement With Equity
Equity Interest. As further consideration, ***** will grant to Stanford shares of (common or preferred) stock in *****. When issued, those shares will represent % of the (common or preferred) stock in ***** on a Fully Fully-Diluted Basis. Prior to signing this Agreement, ***** agrees the shares are valued at (ALTERNATIVE: ask company to provide letter stating value of shares as of the Effective Date, and include letter as Appendix D) and to will provide Stanford with the its capitalization table upon which and the above calculation is maderesults of an independent third-party 409A valuation conducted for the purposes of valuing *****’s common stock. ***** will issue 28.34% of all shares granted to Stanford pursuant to this Section 7.2 and SectionSection 7.3 directly to and in the name of the inventors listed below allocated as stated below: Inventor 1 Inventor 2
Appears in 2 contracts
Samples: Exclusive License Agreement With Equity, Sample Agreement
Equity Interest. As further consideration, ***** Company will grant to Stanford shares of (common or preferred) stock in [*****] shares of common stock in Company. When issued, those shares will represent % of the (common or preferred) stock in [***** on a Fully Diluted Basis] of the outstanding stock in Company. ***** agrees the The shares are valued at (ALTERNATIVE: ask company to provide letter stating value of shares [***] per share as of the Effective Date, and include letter as indicated in Appendix D) and H. Company agrees to provide Stanford with the capitalization table upon which the above calculation is made. Company will issue [***** will issue 28.34% ] of all shares granted to Stanford pursuant to this Section 7.2 and SectionSection 7.3 directly to and in the name of the inventors listed below allocated as stated below: [***]
Appears in 1 contract
Samples: AbCellera Biologics Inc.
Equity Interest. As further consideration, ***** will grant to Stanford shares of (common or preferred) stock in *****. When issued, those shares will represent % of the (common or preferred) stock in ***** on a Fully Diluted Basis. ***** agrees the shares are valued at (ALTERNATIVE: ask company to provide letter stating value of shares as of the Effective Date, and include letter as Appendix D) and to provide Stanford with the capitalization table upon which the above calculation is made. ***** will issue 28.34% of all shares granted to Stanford pursuant to this Section 7.2 and SectionSection 7.3 directly to and in the name of the inventors listed below allocated as stated below: Inventor 1 Inventor 2
Appears in 1 contract
Samples: Exclusive (Equity) Agreement